Pentapeptide and use thereof
AssigneeEnsol Biosciences Inc.
InventorsHae Jin KIM, Eun Joung MOON, Cheol Min LEE, Yun Hee HAN
Life of this patent
Estimating the term…
Abstract
Proposed are a pentapeptide formed by acetylation of the N-terminus of a peptide consisting of an amino acid sequence represented by SEQ ID NO: 1, a pharmaceutically acceptable salt thereof, and uses thereof. The pentapeptide is stable and effective for inhibition of anticancer drug resistance, inhibition of autophagy in tumor cells, enhancement of immunity, activation of immune cells, promotion of anti-tumor immune response, and/or anticancer therapy.
Claims7
A pentapeptide formed by acetylation of the N-terminus of a peptide consisting of an amino acid sequence represented by SEQ ID NO:
- 1, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.